6.7.2 Drugs affecting gonadotrophins
Leuprorelin
Prostap 3 DCS 11.25mg powder and solvent for prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Prostap PD DCS 1.88mg powder and solvent for prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Prostap SR DCS 3.75mg powder and solvent for prolonged-release suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Linzagolix
Linzagolix 100mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Uterine fibroids |
Linzagolix 200mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Uterine fibroids |
Relugolix + Estradiol + Norethisterone acetate
Ryeqo 40mg/1mg/0.5mg tablets
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Endometriosis |
| Obstetrics, gynaecology, and urinary-tract disorders | Uterine fibroids |
Triptorelin
Decapeptyl SR 11.25mg powder and solvent for suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Decapeptyl SR 22.5mg powder and solvent for suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Gonapeptyl Depot 3.75mg powder and solvent for suspension for injection pre-filled syringes
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Endocrine system | Precocious puberty |
Triptorelin 11.25mg powder and solvent for prolonged-release suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Endometriosis |
Triptorelin acetate 3mg powder and solvent for prolonged-release suspension for injection vials
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Obstetrics, gynaecology, and urinary-tract disorders | Endometriosis |